Citação norma APA

Rinnerthaler, G., Gampenrieder, S. P., Hackl, H., Steiner, M., Monzo-Fuentes, C., Melchardt, T., . . . Greil, R. (2020). Low Expression of miR-20a-5p Predicts Benefit to Bevacizumab in Metastatic Breast Cancer Patients Treated within the TANIA Phase III Trial. J Clin Med.

Citação norma Chicago

Rinnerthaler, Gabriel, et al. "Low Expression of MiR-20a-5p Predicts Benefit to Bevacizumab in Metastatic Breast Cancer Patients Treated Within the TANIA Phase III Trial." J Clin Med 2020.

Citação norma MLA

Rinnerthaler, Gabriel, et al. "Low Expression of MiR-20a-5p Predicts Benefit to Bevacizumab in Metastatic Breast Cancer Patients Treated Within the TANIA Phase III Trial." J Clin Med 2020.

Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.